Switching maintenance infliximab therapy to biosimilar infliximab in inflammatory bowel disease patients

Eberl, A; Huoponen, S; Pahikkala, T; Blom, M; Arkkila, P; Sipponen, T

Eberl, A (reprint author), Helsinki Univ Hosp, Dept Gastroenterol, Box 340, FIN-00029 Helsinki, Hus, Finland.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017; 52 (12): 1348

Abstract

Background: Clinical use of biosimilar infliximab (CT-P13) in inflammatory bowel diseases (IBDs) is based on extrapolation of indication from clinical......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索